Lonza Group AG (0QNO.L)
LSE - LSE Delayed price. Currency in CHF
Add to watchlist
At close: 05:36PM BST
| Previous close | 484.93 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 103,234 |
| Market cap | 36.285B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 0.12 |
| EPS (TTM) | 39.52 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
- GuruFocus.com
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
PR NewswireNeuroSense Announces First Quarter 2024 Business Update
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
© 2024 Yahoo. All rights reserved.